Summer 2023 Vol. 13 Issue 02
-
From the Editor-in-Chief
Artificial IntelligenceAI has significant implications for medicine, especially for precision cancer care.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
A Difficult DuoPeople with cancer who have existing mental health conditions may need to double down to get the support they need.
by Hester Hill Schnipper
-
Caregiving With Confidence
Cancer ConfidentialCaregivers and their loved ones may need to set ground rules for communicating sensitive health information.
by K.J. Bannan
-
Policy Matters
Reigniting the MoonshotPresident Biden proposes increased investment in cancer research and prevention to achieve the goals of the revised Cancer Moonshot.
by Roy S. Herbst, MD, PhD
-
Getting Over Weight
Messages about weight are common in the U.S. Stigmatizing cancer patients because of their weight can negatively affect them in a health care setting.
by Eric Fitzsimmons
-
Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
ADCs Make Their Mark
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
-
Q&A
Cancer’s Public PersonaElaine Schattner explores how public discourse has shaped our perception of cancer.
by Marci A Landsmann
-
Get Involved
Baked GoodnessSyreeta Harrison sells homemade cupcakes to fund care packages for people with cancer.
by Thomas Celona
-
Facts and Stats
Know the LingoMedical paperwork can be full of confusing jargon. Use these definitions to better understand the terms found in your pathology report.
by Thomas Celona
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore